Avoid costly surprises when buying a dermatology practice. Validate physician retention risk, payer contracts, malpractice exposure, and CPOM compliance before you close.
Find Dermatology Practice Acquisition TargetsAcquiring a dermatology practice in the $1M–$5M revenue range requires deep scrutiny of physician dependency, dual revenue streams, and state-specific healthcare regulations. Practices trading at 4–7x EBITDA must justify that multiple with clean billing records, diversified payer contracts, and a clinical team that extends beyond the founding dermatologist.
Verify that reported EBITDA is clean, recurring, and not distorted by owner perks or one-time cosmetic revenue spikes. Separate medical billing from cash-pay aesthetic revenue.
Request a 3-year revenue breakdown separating insurance-billed medical dermatology from cash-pay cosmetic services like Botox, fillers, and laser treatments. Verify margins on each stream.
Audit all active payer contracts. Flag Medicare or Medicaid concentration above 40%. Confirm reimbursement rates are at or above regional benchmarks for key CPT codes.
Review accounts receivable aging, denial rates, and collections efficiency. High denial rates or aging AR over 120 days may signal systemic billing problems or coding compliance gaps.
Assess key-person dependency, provider employment agreements, and the quality of clinical infrastructure. A single-physician practice presents meaningful post-close revenue risk.
Review all dermatologist, PA, and NP contracts for term, compensation structure, non-compete enforceability, and termination triggers. Confirm post-close retention commitments from key providers.
Determine what percentage of revenue is driven by the founding physician. If one provider generates over 70% of revenue, model downside scenarios and negotiate earnout provisions accordingly.
Analyze 24-month appointment data by provider, visit type, and payer. Look for declining medical appointment volume masked by growing cosmetic revenue, and flag elevated no-show rates.
Healthcare acquisitions require compliance with corporate practice of medicine laws, malpractice review, and proper entity structuring to ensure a legally defensible transaction.
Obtain a full 10-year malpractice claims history. Confirm whether policies are claims-made or occurrence-based, and establish whether tail coverage is required and who bears that cost.
Verify state-specific corporate practice of medicine laws. Most dermatology acquisitions require an MSO structure or physician equity rollover. Engage a healthcare M&A attorney before LOI.
Confirm lease term with renewal options and landlord assignment consent. Validate all state licenses, DEA registrations, and Medicare or Medicaid provider enrollment numbers are current.
Independent dermatology practices typically trade at 4–7x EBITDA. Higher multiples apply to practices with strong cosmetic revenue, multiple providers, and diversified payer mix with minimal Medicare concentration.
Yes. Dermatology practices are SBA-eligible. Most deals combine an SBA 7(a) loan with a seller note covering 10–15% of the purchase price, plus a 12–24 month seller transition period to protect revenue continuity.
Most states prohibit non-physicians from owning medical practices. Acquirers typically use an MSO structure, separating clinical operations from administrative management, or require physician equity rollover to maintain compliant ownership.
A single physician generating over 80% of revenue with no succession plan or signed post-close employment agreement. This key-person risk can collapse practice value rapidly if that provider departs after closing.
More Dermatology Practice Guides
DealFlow OS surfaces targets with seller signals and motivation scores — so you know before you start diligence. Free to join.
Start finding deals — freeNo credit card required
For Buyers
For Sellers